Anastasios Stathis retweeted
MDICT 2024 recommendations for neoadjuvant early clinical trials now published. Led by ESMO-TAT chairs @lillian_siu @ElenaGarralda @AnastasiosStat2 and MDICT’24 team supported by @myESMO
sciencedirect.com/science/ar…
Anastasios Stathis retweeted
Great session this afternoon on #oncology #drug development 💉💊
#Biotech status & prospects
Fruitful live discussion & interaction
#ESMOTAT24 – at Paris, France
Anastasios Stathis retweeted
#ESMOTAT2023 starting. Amazing agenda and very excited to see so many attendees from all over the world in this important drug development meeting👏👏👏
Anastasios Stathis retweeted
ESMO announces Funda Meric-Bernstam as the recipient of 2024 TAT Honorary Award for her outstanding contributions to #PrecisionOncology.
📅 She will deliver her award lecture on 26 February at the #ESMOTAT24 in Paris
📌ow.ly/nTmE50QymhO.
Anastasios Stathis retweeted
#ESMOTAT24: Early registration deadline 📢⏲️ 10 January 2024 at 23:59 (CET). Watch @LSeymourMD, Shivaani Kummar, Irene Braña, Timothy Yap, @lillian_siu, @ElenaGarralda & @AnastasiosStat2 give their takes on why you should attend. 👇
ow.ly/8W3X50Qp5TU
Replying to @thanosplevris
Αραγε τι σημαια έχεις κρεμασμένη εσυ στο σπίτι σου κύριε (με ποια προσόντα;) πρώην υπουργέ υγείας;
22
Anastasios Stathis retweeted
#ESMOTAT24: Last few hours to make sure you are part of this international multi-stakeholder forum in the early drug development arena. ⏰Abstract submission deadline today (28/11, 21:00 CET)
ow.ly/PSnM50QbS8G
@lillian_siu @ElenaGarralda @AnastasiosStat2
Anastasios Stathis retweeted
#ESMOTAT24: Be part of this international multi-stakeholder forum in the early drug development arena! Merit travel grants are available. ⏰Abstract submission deadline: 28 November 2023.
ow.ly/HsQL50PR0G4
@lillian_siu @ElenaGarralda @AnastasiosStat2
Anastasios Stathis retweeted
#ESMOTAT24: Shape the future of cancer #drugdevelopment and take part in this unique forum gathering all relevant stakeholders in #oncology. ⏰Abstract submission deadline: 28 November 2023.
ow.ly/HC3A50PLsEJ
@lillian_siu @ElenaGarralda @AnastasiosStat2
Replying to @PrimeministerGR
Πόσοι άνθρωποι έχασαν την ζωή τους κ Πρωθυπουργέ;
Anastasios Stathis retweeted
#ESMOTAT24 taking place Feb 26-28, 2024, in Paris! Abstract submission now open till Nov 28, 2023: esmo.org/meeting-calendar/es… @myESMO
New meeting features with parallel industry sessions - not to be missed
Anastasios Stathis retweeted
Dall’EOC cinque nuovi Professori titolari per la Facoltà di scienze biomediche dell’USI.
Comunicato stampa: eoc.ch/comunicazione/Comunic…
Replying to @thanosplevris
Ακόμα δεν έχω καταλάβει για ποιον λόγο είστε υπουργός υγείας στην Ελλάδα.
1
74
Replying to @thanosplevris
Το σύστημα υγείας στην Ελλάδα είναι κατεστραμμένο και έχετε τεράστια ευθύνη και εσείς και οι φίλοι σας διοικητές των νοσοκομείων (που γίνονται φυσικά διοικητές μόνο επειδή φίλοι σας)
34
Anastasios Stathis retweeted
📢🗓The #17ICML Scientific Program, based on more than 800 submitted abstracts, is almost ready!
Watch the video to have a sneak peek of the 17-ICML and stay tuned!
Anastasios Stathis retweeted
The abstract of the other one of our two #AACR23 #lymphoma posters. @IOR_Bellinzona @USI_en @EnteOspedaliero @CascioneLuciano @AnastasiosStat2 @SpexisAg
Adding CXCR4 inhibition to improve activity of anti-lymphoma agents:
abstractsonline.com/pp8/#!/1…
Anastasios Stathis retweeted
The abstract of one of our two #AACR23 #lymphoma posters. @IOR_Bellinzona @USI_en @EnteOspedaliero @CascioneLuciano @AnastasiosStat2 @ManelEsteller
ERBB4 as resistance to BTK and PI3K inhibitors in lymphomas:
abstractsonline.com/pp8/#!/1…
















